Natural killer cells were long overshadowed by T-cell therapies. Now a growing field is trying to unleash them — with the promise of off-the-shelf, lower-toxicity treatments for cancers that have resisted everything else. SAN FRANCISCO, June 12, 2026 — Equity Insider News Commentary — The last decade of cancer immunotherapy was written largely in the language […]

America can build data centers in months, but the electricity to run them can take half a decade to arrive. That gap is becoming one of the biggest investment stories of the decade — and a NASDAQ-listed company is repositioning itself to sit right inside it. BOCA RATON, Fla., June 12, 2026 — Equity Insider News […]